These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 24001249)

  • 1. Are prescription drug insurance choices consistent with expected utility theory?
    Bundorf MK; Mata R; Schoenbaum M; Bhattacharya J
    Health Psychol; 2013 Sep; 32(9):986-94. PubMed ID: 24001249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation in Prescription Drug Coverage Enrollment Among Vulnerable Beneficiaries With Glaucoma Before and After the Implementation of Medicare Part D.
    Blumberg DM; Prager AJ; Liebmann JM
    JAMA Ophthalmol; 2016 Feb; 134(2):212-20. PubMed ID: 26720853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.
    Cline RR; Worley MM; Schondelmeyer SW; Schommer JC; Larson TA; Uden DL; Hadsall RS
    Res Social Adm Pharm; 2010 Jun; 6(2):130-42. PubMed ID: 20511112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choice set size and decision making: the case of Medicare Part D prescription drug plans.
    Bundorf MK; Szrek H
    Med Decis Making; 2010; 30(5):582-93. PubMed ID: 20228281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients.
    Tseng CW; Brook RH; Keeler E; Mangione CM
    JAMA; 2003 Jul; 290(2):222-7. PubMed ID: 12851277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Out-of-pocket health spending by poor and near-poor elderly Medicare beneficiaries.
    Gross DJ; Alecxih L; Gibson MJ; Corea J; Caplan C; Brangan N
    Health Serv Res; 1999 Apr; 34(1 Pt 2):241-54. PubMed ID: 10199672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescription drugs: issues of cost, coverage, and quality.
    Copeland C
    EBRI Issue Brief; 1999 Apr; (208):1-21. PubMed ID: 10539445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicare program; Medicare prescription drug benefit. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Jan; 70(18):4193-585. PubMed ID: 15678603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of satisfaction and switching costs in Medicare Part D choices.
    Han J; Ko DW; Urmie JM
    Res Social Adm Pharm; 2014; 10(2):398-407. PubMed ID: 23988694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increases in Medicare prescription drug plan costs attributable to psychotropic medications.
    Zivin K; McCammon RJ; Davis MM; Halasyamani LK; Kales HC
    Am J Geriatr Psychiatry; 2008 Aug; 16(8):674-85. PubMed ID: 18669946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nothing for something? Estimating cost and value for beneficiaries from recent medicare spending increases on HMO payments and drug benefits.
    Pizer SD; Frakt AB; Feldman R
    Int J Health Care Finance Econ; 2009 Mar; 9(1):59-81. PubMed ID: 18821013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the Affordable Care Act's young adult insurance expansion on prescription drug insurance coverage, utilization, and expenditures.
    Look KA; Arora P
    Res Social Adm Pharm; 2016; 12(5):682-98. PubMed ID: 26632980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing employer-sponsored and federal exchange plans: wide variations in cost sharing for prescription drugs.
    Buttorff C; Andersen MS; Riggs KR; Alexander GC
    Health Aff (Millwood); 2015 Mar; 34(3):467-76. PubMed ID: 25732498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A first look at the new Medicare prescription drug plans.
    Frakt AB; Pizer SD
    Health Aff (Millwood); 2006; 25(4):W252-61. PubMed ID: 16720588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicare prescription drug plan coverage of pharmacotherapies for opioid and alcohol dependence in WA.
    Kennedy J; Dipzinski A; Roll J; Coyne J; Blodgett E
    Drug Alcohol Depend; 2011 Apr; 114(2-3):201-6. PubMed ID: 21134724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies used by adults to reduce their prescription drug costs.
    Cohen RA; Kirzinger WK; Gindi RM
    NCHS Data Brief; 2013 Apr; (119):1-8. PubMed ID: 23742848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The health plan choices of retirees under managed competition.
    Buchmueller TC
    Health Serv Res; 2000 Dec; 35(5 Pt 1):949-76. PubMed ID: 11130806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring prescription drug coverage and drug use for older americans.
    Mott DA; Schommer JC
    Ann Pharmacother; 2002 Nov; 36(11):1704-11. PubMed ID: 12398563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demand for a Medicare prescription drug benefit: exploring consumer preferences under a managed competition framework.
    Cline RR; Mott DA
    Inquiry; 2003; 40(2):169-83. PubMed ID: 13677564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.